GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (STU:SRT) » Definitions » Cyclically Adjusted PS Ratio

Sartorius AG (STU:SRT) Cyclically Adjusted PS Ratio : 5.49 (As of May. 24, 2024)


View and export this data going back to . Start your Free Trial

What is Sartorius AG Cyclically Adjusted PS Ratio?

As of today (2024-05-24), Sartorius AG's current share price is €205.00. Sartorius AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €37.31. Sartorius AG's Cyclically Adjusted PS Ratio for today is 5.49.

The historical rank and industry rank for Sartorius AG's Cyclically Adjusted PS Ratio or its related term are showing as below:

STU:SRT' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.75   Med: 9.2   Max: 33.28
Current: 5.67

During the past years, Sartorius AG's highest Cyclically Adjusted PS Ratio was 33.28. The lowest was 4.75. And the median was 9.20.

STU:SRT's Cyclically Adjusted PS Ratio is ranked worse than
74.26% of 474 companies
in the Medical Devices & Instruments industry
Industry Median: 2.2 vs STU:SRT: 5.67

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sartorius AG's adjusted revenue per share data for the three months ended in Mar. 2024 was €11.836. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €37.31 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sartorius AG Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Sartorius AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Cyclically Adjusted PS Ratio Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.34 16.43 19.33 10.52 7.25

Sartorius AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.47 7.47 7.40 7.25 7.29

Competitive Comparison of Sartorius AG's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Sartorius AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Cyclically Adjusted PS Ratio falls into.



Sartorius AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Sartorius AG's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=205.00/37.31
=5.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Sartorius AG's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=11.836/125.0381*125.0381
=11.836

Current CPI (Mar. 2024) = 125.0381.

Sartorius AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 3.242 99.543 4.072
201409 3.263 99.823 4.087
201412 3.639 99.543 4.571
201503 3.757 99.717 4.711
201506 4.093 100.417 5.097
201509 4.358 100.417 5.427
201512 4.195 99.717 5.260
201603 4.348 100.017 5.436
201606 13.000 100.717 16.139
201609 4.925 101.017 6.096
201612 4.954 101.217 6.120
201703 4.901 101.417 6.043
201706 5.187 102.117 6.351
201709 5.000 102.717 6.087
201712 5.494 102.617 6.694
201803 5.213 102.917 6.333
201806 5.768 104.017 6.934
201809 5.796 104.718 6.921
201812 6.119 104.217 7.341
201903 6.340 104.217 7.607
201906 6.704 105.718 7.929
201909 6.741 106.018 7.950
201912 6.933 105.818 8.192
202003 7.443 105.718 8.803
202006 8.066 106.618 9.460
202009 9.132 105.818 10.791
202012 9.617 105.518 11.396
202103 11.477 107.518 13.347
202106 12.221 108.486 14.086
202109 13.077 109.435 14.942
202112 13.481 110.384 15.271
202203 14.946 113.968 16.398
202206 15.116 115.760 16.327
202209 15.365 118.818 16.169
202212 15.520 119.345 16.260
202303 13.194 122.402 13.478
202306 12.174 123.140 12.362
202309 12.255 124.195 12.338
202312 12.421 123.773 12.548
202403 11.836 125.038 11.836

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sartorius AG  (STU:SRT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Sartorius AG Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG (STU:SRT) Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.